Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation

Autor(es):Mostrar menos -

Gomes, Diego Juvenal ; Velosa, Ana Paula ; Okuda, Ligia Shimabukuro ; Fusco, Fernanda Bueno ; da Silva, Karolinne Santana ; Pinto, Paula Ramos ; Nakandakare, Edna Regina ; Correa-Giannella, Maria Lucia ; Woods, Tom ; Brimble, Margaret Anne ; Pickford, Russell ; Rye, Kerry-Anne ; Teodoro, Walcy Rosolia ; Catanozi, Sergio ; Passarelli, Marisa

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF DIABETES AND ITS COMPLICATIONS; v. 30, n. 8, p. 1614-1621, NOV-DEC 2016.
• Citações Web of Science: 2

Resumo

Aims: Advanced glycated albumin (AGE-albumin) adversely impairs macrophage lipid homeostasis in vitro, which may be prevented by angiotensin receptor blockers. In vivo studies are inconclusive whether AGE-albumin itself plays important role in early-stage atherogenesis. We aimed at investigating how AGE-albumin by itself drives atherosclerosis development in dyslipidemic non-diabetic mice and if its effects are due to the activation of renin-angiotensin system in the arterial wall and the expression of genes and proteins involved in lipid flux. Methods and results: Murine albumin glycation was induced by incubation with 10 mM glycolaldehyde and C-albumin with PBS alone. Twelve-week-old-male apoE knockout mice were submitted to a daily IP injection of control (C) or AGE-albumin (2 mg/mL) during 30 days with or without losartan (LOS: 100 mg/L; C + LOS and AGE + LOS). Aortic arch was removed, and gene expression was determined by RT-PCR and protein content by immunofluorescence. Plasma lipid and glucose levels were similar among groups. Systolic blood pressure was similarly reduced in both groups treated with LOS. In comparison to C-albumin, aortic lipid infiltration was 5.3 times increased by AGE-albumin, which was avoided by LOS. LOS prevented the enhancement induced by AGE-albumin in Ager, Tnf and Cybb mRNA levels but did not reduce Olrl. Nfkb and Agt mRNA levels were unchanged by AGE-albumin. LOS similarly reduced Agtri a mRNA level in both C and AGE-albumin groups. In AGE-albumin-treated mice, immunofluorescence for carboxymethyl-lysine, 4-hydroxynonenal and RAGE was respectively, 4.8, 2.6 and 1.7 times enhanced in comparison to C-albumin. These increases were all avoided by LOS. Conclusions: AGE-albumin evokes a pre-stage of atherogenesis in dyslipidemic mice independently of the presence of diabetes mellitus or modulation in the RAS in part by the induction of lipid peroxidation and inflammation. (C) 2016 Elsevier Inc. All rights reserved. (AU)

• Processo FAPESP: 11/04631-0 - Produtos de glicação avançada e sistema renina-angiotensina: impacto sobre o desenvolvimento da aterosclerose em camundongos dislipidêmicos
• Beneficiário: Diego Juvenal Gomes
• Linha de fomento: Bolsas no Brasil - Mestrado
• Processo FAPESP: 12/19755-9 - Produtos de glicação avançada e sistema renina-angiotensina: impacto sobre o desenvolvimento da aterosclerose em camundongos dislipidêmicos
• Beneficiário: Marisa Passarelli
• Linha de fomento: Auxílio à Pesquisa - Regular
• Processo FAPESP: 13/11084-0 - Restrição crônica de cloreto de sódio e gênese de aterosclerose em modelo animal de dislipidemia e hipertensão arterial
• Beneficiário: Sergio Catanozi
• Linha de fomento: Auxílio à Pesquisa - Regular
• Processo FAPESP: 07/56654-8 - Secreção de mediadores inflamatórios e transporte reverso de colesterol em macrófagos submetidos a glicoxidação
• Beneficiário: Ligia Shimabukuro Okuda
• Linha de fomento: Bolsas no Brasil - Mestrado
• Processo FAPESP: 13/02854-7 - Função anti-inflamatória da apolipoproteína A-IV no diabete melito e seu reflexo sobre o transporte reverso de colesterol de macrófagos: influência da modificação por glicação avançada
• Beneficiário: Ligia Shimabukuro Okuda
• Linha de fomento: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 11/16164-7 - Losartana e hidralazina previnem o acúmulo arterial de lípides induzido pela restrição alimentar crônica de sódio em animais hipertensos e hiperlipidêmicos
• Beneficiário: Fernanda Bueno Fusco
• Linha de fomento: Bolsas no Brasil - Mestrado
• Processo FAPESP: 13/23392-1 - Função anti-inflamatória da apolipoproteína A-IV no diabete melito e seu reflexo sobre o transporte reverso de colesterol de macrófagos: influência da modificação por glicação avançada
• Beneficiário: Ligia Shimabukuro Okuda
• Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado